Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose

Background Dupilumab has been shown to improve clinical outcomes long term while reducing oral corticosteroid (OCS) dose in patients with severe OCS-dependent asthma. This post hoc analysis assesses the impact of OCS dose at baseline (≤10 or >10 mg·day−1) on long-term outcomes of dupilumab treatm...

詳細記述

書誌詳細

出版年:	ERJ Open Research
主要な著者:	Christian Domingo, Klaus F. Rabe, David Price, Guy Brusselle, Michael E. Wechsler, Changming Xia, Nami Pandit-Abid, Rebecca Gall, Paul J. Rowe, Yamo Deniz, Juby A. Jacob-Nara, Amr Radwan
フォーマット:	論文
言語:	英語
出版事項:	European Respiratory Society 2023-11-01
オンライン･アクセス:	http://openres.ersjournals.com/content/9/6/00056-2023.full